臨床検査52巻3号

2008年03月発行

今月の主題 アルツハイマー病の最近の進歩 各論─診断・治療・予防

アルツハイマー病の抗体治療

著者： 松原悦朗¹

所属機関： ¹国立長寿医療センター研究所アルツハイマー病研究部

ページ範囲：P.297 - P.301

　アルツハイマー病の抗体治療は，その根本治療の可能性を秘めた魅力的な治療法である．現在世界中で熾烈な競争下にあり，臨床の場に登場してくる日も近いと考えられている．

参考文献

1) Schenk D, Barbour R, Dunn W, et al：Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature　400：173-177, 1999

2) Bard F, Cannon C, Barbour R, et al：Peripherally administrated antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in mouse model of Alzheimer disease. Nat Med　6：916-919, 2000

3) Janus C, Pearson J, McLaurin J, et al：A beta peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature　408：979-982, 2000

4) Morgan D, Diamond DM, Gottschall PE, et al：Abeta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature　408：982-985, 2000

5) Weiner HL, Lemere CA, Maron R, et al：Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol　48：567-579, 2000

6) Orgogozo JM, Gilman S, Dartigues JF, et al：Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology　61：46-54, 2003

7) Nicoll JAR, Wilkinson D, Holmes C, et al：Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide：a case report. Nat Med　9：448-452, 2003

8) Bard F, Barbour R, Cannon C, et al：Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci USA　100：2023-2028, 2003

9) Das P, Howard V, Loosbrock N, et al：Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/-knock-out mice. J Neurosci　23：8352-8538, 2003

10) Matsuoka Y, Saito M, LaFrancois J, et al：Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci　23：29-33, 2003

11) Dodart JC, Bales KR, Gannon KS, et al：Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci　5：452-457, 2002

12) Kotilinek LA, Bascskai B, Weserman M, et al：Reversible memory loss in mouse transgenic model of Alzheimer's disease. J Neurosci　22：6331-6335, 2002

13) Asami-Odaka A, Obayashi-Adachi Y, Matsumoto Y, et al：Passive immunization of Abeta42(43)C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease. Neurodegener Dis　2：36-43, 2005

14) DeMattos RB, Bales KR, Cummins DJ, et al：Peripheral anti-Abeta antibody alters CNS and plasma Abeta clearance and decreases Abeta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA　98：8850-8855, 2001

15) Wilcock DM, Rojiani A, Rosenthal A, et al：Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci　24：6144-6151, 2004

16) Levites Y, Das P, Price RW, et al：Anti-Aβ42- and anti-Aβ40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest　116：193-201, 2006

17) Lee EB, Leng LZ, Zhang B, et al：Targeting amyloid beta peptide(Abeta)oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein(APP)transgenic mice. J Biol Chem　281：4292-4299, 2006

18) Yamamoto N, Yokoseki T, Shibata M, et al：Suppression of Abeta deposition in brain by peripheral administration of Fab fragments of anti-seed antibody. Biochem Biophys Res Commun　335：45-47, 2005

19) Pfeifer M, Boncristiano S, Bondolfi L, et al：Cerebral hemorrhage after passive anti-Aβ immunotherapy. Science　298：1379, 2002

20) Racke MM, Boone LI, Hepburn DL, et al：Exacerbation of cerebral amyloid angiopathy-associated microhemorrage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid β. J Neurosci　25：629-636, 2005

21) Lee B, Leng LZ, Lee VMY, et al：Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis. FEBS Lett　579：2564-2568, 2005

22) Weksler ME, Gouras G, Relkin NR, et al：The immune system, amyloid-beta peptide, and Alzheimer's disease. Immunol Rev　205：244-256, 2005